XARELTO LINKED TO INTERNAL BLEEDING AND WRONGFUL DEATH
Xarelto was jointly developed by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, and Bayer Health Care. Xarelto is an anticoagulant used to reduce the risk of stroke, blood clots, pulmonary embolism, and deep vein thrombosis. Xarelto has been linked to a substantially higher risk of internal bleeding than its competitors.
Johnson & Johnson promoted Xarelto as a more effective alternative to Coumadin, since it allegedly required less frequent monitoring; while knowing the drug did not have an approved reversal agent. Without an adequate reversal agent, physicians were unable to control bleeding problems that could arise.
Reports have shown that Xarelto use has led to uncontrollable bleeding and increased risk of serious injury and death. Johnson & Johnson and Bayer failed to provide warnings, communicate the increased risk of serious injury associated with Xarelto use, and have continued to promote this drug for large profits without an approved reversal agent.
Xarelto Is Known to Cause Serious Side Effects
Although Xarelto has been marketed as a helpful drug, it has been known to cause serious side effects. Despite the harm that Xarelto can cause, Johnson & Johnson continued to market the drug. Side effects of Xarelto use include:
- Internal Bleeding
- Gastrointestinal Bleeding
- Kidney Bleeding
- Brain Bleeds
- Death resulting from excessive bleeding
These medical conditions can be life threatening and life altering. The medical bills, prescription drugs, co-pays, and medical equipment necessary to cope with impacts an uncontrolled Xarelto bleed can cause can be devastating. Also, victims of brain bleeds, or gastrointestinal bleeds may find themselves out of work for a long period of time or unable to work again. The loss of income and medical costs can be crippling for an individual and their family.
If you or a loved one has been injured as a result of an uncontrolled Xarelto induced bleed, contact Chelsie King Garza for a free consultation.